Pharmaceutical / Drug Definition :
Inhibits osteoclast-mediated bone by blocking resorption of mineralized bone and cartilage, eventually causing cell death and limiting tumor growth. Also limits calcium release produced by tumor.
FDA Label Requirements and Exceptions
FDA Import Information
Zoledronic Acid (Zoledronic Acid Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Zoledronic Acid (Zoledronic Acid Suppliers)
- Processors Zoledronic Acid
- Repackers Zoledronic Acid
- Relabelers Zoledronic Acid
- Exporters Zoledronic Acid
- Importers Zoledronic Acid
For more information about Zoledronic Acid, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.